HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Addis-Lieser, E. Articles by Chiaramonte, M. G. Search for Related Content PubMed PubMed Citation Articles by Addis-Lieser, E. Articles by Chiaramonte, M. G.

Opposing Regulatory Roles of Complement Factor 5 in the Development of Bleomycin-Induced Pulmonary Fibrosis¹

Erin Addis-Lieser^*, Jörg Köhl and Mónica G. Chiaramonte^2,*

^* Division of Immunobiology and Division of Molecular Immunology, Cincinnati Children’s Hospital Research Foundation, Department of Pediatrics, University of Cincinnati, Cincinnati, OH 45229

The mechanisms of idiopathic pulmonary fibrosis pathogenesis, a chronic and progressive interstitial lung disease, remain elusive. The complement system, a crucial arm of the innate immune response, plays a pivotal role in several pathological disorders; however, the contribution of individual complement components to lung fibrosis has not yet been examined. Complement factor 5 (C5) and its cleavage product C5a are critical mediators in inflammatory diseases. Thus, to evaluate the role of C5 in lung fibrosis, we compared congenic C5-sufficient and C5-deficient mice in a well-characterized murine model of bleomycin-induced pulmonary fibrosis. C5-deficient mice had an exaggerated inflammatory phenotype compared with C5-sufficient mice during acute bleomycin-induced lung injury. These findings suggest a protective and anti-inflammatory role for C5, which was linked to the regulation of matrix metalloproteinases involved in cell migration. In contrast, C5 had a detrimental effect during chronic stages of bleomycin-induced injury, indicating a profibrotic role for C5. This deleterious activity for C5 was associated with expression of the fibrogenic cytokine TGF-1 and matrix metalloproteinase-3, an important mediator in fibroblast contraction. Altogether, our data reveal novel and opposing roles for C5 in both inflammation and tissue repair. Furthermore, these findings provide insight into the development of new therapeutic strategies for idiopathic pulmonary fibrosis patients.

This article has been cited by other articles:

				W. D. Hardie, T. R. Korfhagen, M. A. Sartor, A. Prestridge, M. Medvedovic, T. D. Le Cras, M. Ikegami, S. C. Wesselkamper, C. Davidson, M. Dietsch, et al. Genomic Profile of Matrix and Vasculature Remodeling in TGF-{alpha} Induced Pulmonary Fibrosis Am. J. Respir. Cell Mol. Biol., September 1, 2007; 37(3): 309 - 321. [Abstract] [Full Text] [PDF]

				P. Boor, A. Konieczny, L. Villa, A.-L. Schult, E. Bucher, S. Rong, U. Kunter, C. R.C. van Roeyen, T. Polakowski, H. Hawlisch, et al. Complement C5 Mediates Experimental Tubulointerstitial Fibrosis J. Am. Soc. Nephrol., May 1, 2007; 18(5): 1508 - 1515. [Abstract] [Full Text] [PDF]

				J. Wehner, C. N. Morrell, T. Reynolds, E. R. Rodriguez, and W. M. Baldwin III Antibody and Complement in Transplant Vasculopathy Circ. Res., February 2, 2007; 100(2): 191 - 203. [Abstract] [Full Text] [PDF]

				A. Mullick, Z. Leon, G. Min-Oo, J. Berghout, R. Lo, E. Daniels, and P. Gros Cardiac Failure in C5-Deficient A/J Mice after Candida albicans Infection. Infect. Immun., August 1, 2006; 74(8): 4439 - 4451. [Abstract] [Full Text] [PDF]